General Information of the Compound
Compound ID
CP0114970
Compound Name
(S)-(-)-N-(R-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide
    Show/Hide
Synonyms
3-hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide
N-((S)-alpha-Ethylbenzyl)-3-hydroxy-2-phenylcinchoninamide;N-(alpha-Ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide
SB 223412
SB-223412
Talnetant
Talnetant [INN]
    Show/Hide
Structure
Formula
C25H22N2O2
Molecular Weight
382.463
Canonical SMILES
CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1
    Show/Hide
InChIKey
BIAVGWDGIJKWRM-FQEVSTJZSA-N
CAS
174636-32-9
Physicochemical Property
logP
5.4885
Rotatable Bonds
5
Heavy Atom Count
29
Polar Areas
62.22
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5311424
SID: 57304378
ChEMBL ID
CHEMBL10188
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 1860 nM
   TI
   LI
   LO
   TS
Protein ID: PT01199, Neuromedin-K receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  5
1
IC50 = 2.4 nM
   TI
   LI
   LO
   TS
2
IC50 = 8.4 nM
   TI
   LI
   LO
   TS
3
Ki = 1 nM
   TI
   LI
   LO
   TS
4
Ki = 7.943 nM
   TI
   LI
   LO
   TS
5
Ki = 254 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  13
1
IC50 = 6.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 16.6 nM
   TI
   LI
   LO
   TS
3
Kd = 2.344 nM
   TI
   LI
   LO
   TS
4
Kd = 2.884 nM
   TI
   LI
   LO
   TS
5
Kd = 5.754 nM
   TI
   LI
   LO
   TS
6
Kd = 229.09 nM
   TI
   LI
   LO
   TS
7
Ki = 1.7 nM
   TI
   LI
   LO
   TS
8
Ki = 3 nM
   TI
   LI
   LO
   TS
9
Ki = 3.6 nM
   TI
   LI
   LO
   TS
10
Ki = 3.7 nM
   TI
   LI
   LO
   TS
11
Ki = 10.6 nM
   TI
   LI
   LO
   TS
12
Ki = 37.2 nM
   TI
   LI
   LO
   TS
13
Ki = 122 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 7.4 nM
Protein ID: PT05029, Neuromedin-K receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  4
1
Kd = 12.3 nM
   TI
   LI
   LO
   TS
2
Kd = 15.49 nM
   TI
   LI
   LO
   TS
3
Ki = 3.8 nM
   TI
   LI
   LO
   TS
4
Ki = 5 nM
   TI
   LI
   LO
   TS
Protein ID: PT01290, Substance-K receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 144 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 3700 nM
2 Ki = 3981.07 nM
Protein ID: PT01410, Substance-P receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 12589.25 nM
2 Ki > 10000 nM
Clinical Information about the Compound
Drug 1 ( Talnetant )
Drug Name Talnetant
Company GlaxoSmithKline
Indication
Schizophrenia
Phase 2
Schizoaffective disorder
Discontinued in Phase 2
Irritable bowel syndrome
Discontinued in Phase 2
Target(s)
Neuromedin-K receptor (TACR3)
Antagonist